[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Mucormycosis Market Report (Status and Outlook)

October 2018 | 116 pages | ID: 2055E9079DFEN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Mucormycosis market for 2018-2023.

Mucormycosis is any fungal infection caused by fungi in the order Mucorales. Generally, species in the Mucor, Rhizopus, Absidia, and Cunninghamella genera are most often implicated. The disease is often characterized by hyphae growing in and around blood vessels and can be potentially life-threatening in diabetic or severely immunocompromised individuals.
If mucormycosis is suspected, amphotericin B therapy should be immediately administered due to the rapid spread and high mortality rate of the disease. Amphotericin B is usually administered for an additional 4–6 weeks after initial therapy begins to ensure eradication of the infection. After administration of either amphotericin B or posaconazole, surgical removal of the 'fungus ball' is indicated. The disease must be monitored carefully for any signs of reemergence.
Over the next five years, LPI(LP Information) projects that Mucormycosis will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Mucormycosis market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • Rhizopus
  • Rhizomucor
  • Apophysomyces
  • Saksenaea
  • Lichtheimia (Absidia)
  • Mucor
Segmentation by application:
  • Hospitals & Clinics
  • Medical Institutes
  • Research Organization
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • Abbott Laboratories
  • Biocon
  • Cadila Pharmaceuticals
  • Novartis
  • Merck
  • Roche
  • Bristol Myers Squibb
  • Pfizer
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Mucormycosis market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Mucormycosis market by identifying its various subsegments.
  • Focuses on the key global Mucormycosis players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Mucormycosis with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Mucormycosis submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mucormycosis Market Size 2013-2023
  2.1.2 Mucormycosis Market Size CAGR by Region
2.2 Mucormycosis Segment by Type
  2.2.1 Rhizopus
  2.2.2 Rhizomucor
  2.2.3 Cunninghamella
  2.2.4 Apophysomyces
  2.2.5 Saksenaea
  2.2.6 Lichtheimia (Absidia)
  2.2.7 Mucor
2.3 Mucormycosis Market Size by Type
  2.3.1 Global Mucormycosis Market Size Market Share by Type (2013-2018)
  2.3.2 Global Mucormycosis Market Size Growth Rate by Type (2013-2018)
2.4 Mucormycosis Segment by Application
  2.4.1 Hospitals & Clinics
  2.4.2 Medical Institutes
  2.4.3 Research Organization
2.5 Mucormycosis Market Size by Application
  2.5.1 Global Mucormycosis Market Size Market Share by Application (2013-2018)
  2.5.2 Global Mucormycosis Market Size Growth Rate by Application (2013-2018)

3 GLOBAL MUCORMYCOSIS BY PLAYERS

3.1 Global Mucormycosis Market Size Market Share by Players
  3.1.1 Global Mucormycosis Market Size by Players (2016-2018)
  3.1.2 Global Mucormycosis Market Size Market Share by Players (2016-2018)
3.2 Global Mucormycosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MUCORMYCOSIS BY REGIONS

4.1 Mucormycosis Market Size by Regions
4.2 Americas Mucormycosis Market Size Growth
4.3 APAC Mucormycosis Market Size Growth
4.4 Europe Mucormycosis Market Size Growth
4.5 Middle East & Africa Mucormycosis Market Size Growth

5 AMERICAS

5.1 Americas Mucormycosis Market Size by Countries
5.2 Americas Mucormycosis Market Size by Type
5.3 Americas Mucormycosis Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Mucormycosis Market Size by Countries
6.2 APAC Mucormycosis Market Size by Type
6.3 APAC Mucormycosis Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Mucormycosis by Countries
7.2 Europe Mucormycosis Market Size by Type
7.3 Europe Mucormycosis Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mucormycosis by Countries
8.2 Middle East & Africa Mucormycosis Market Size by Type
8.3 Middle East & Africa Mucormycosis Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL MUCORMYCOSIS MARKET FORECAST

10.1 Global Mucormycosis Market Size Forecast (2018-2023)
10.2 Global Mucormycosis Forecast by Regions
  10.2.1 Global Mucormycosis Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Mucormycosis Forecast by Type
10.8 Global Mucormycosis Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Company Details
  11.1.2 Mucormycosis Product Offered
  11.1.3 Abbott Laboratories Mucormycosis Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Abbott Laboratories News
11.2 Biocon
  11.2.1 Company Details
  11.2.2 Mucormycosis Product Offered
  11.2.3 Biocon Mucormycosis Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Biocon News
11.3 Cadila Pharmaceuticals
  11.3.1 Company Details
  11.3.2 Mucormycosis Product Offered
  11.3.3 Cadila Pharmaceuticals Mucormycosis Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Cadila Pharmaceuticals News
11.4 Novartis
  11.4.1 Company Details
  11.4.2 Mucormycosis Product Offered
  11.4.3 Novartis Mucormycosis Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Novartis News
11.5 Merck
  11.5.1 Company Details
  11.5.2 Mucormycosis Product Offered
  11.5.3 Merck Mucormycosis Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Merck News
11.6 Roche
  11.6.1 Company Details
  11.6.2 Mucormycosis Product Offered
  11.6.3 Roche Mucormycosis Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Roche News
11.7 Bristol Myers Squibb
  11.7.1 Company Details
  11.7.2 Mucormycosis Product Offered
  11.7.3 Bristol Myers Squibb Mucormycosis Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Bristol Myers Squibb News
11.8 Pfizer
  11.8.1 Company Details
  11.8.2 Mucormycosis Product Offered
  11.8.3 Pfizer Mucormycosis Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Pfizer News

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of Mucormycosis
Figure Mucormycosis Report Years Considered
Figure Market Research Methodology
Figure Global Mucormycosis Market Size Growth Rate 2013-2023 ($ Millions)
Table Mucormycosis Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Rhizopus
Table Major Players of Rhizomucor
Table Major Players of Cunninghamella
Table Major Players of Apophysomyces
Table Major Players of Saksenaea
Table Major Players of Lichtheimia (Absidia)
Table Major Players of Mucor
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Mucormycosis Market Size Market Share by Type (2013-2018)
Figure Global Mucormycosis Market Size Market Share by Type (2013-2018)
Figure Global Rhizopus Market Size Growth Rate
Figure Global Rhizomucor Market Size Growth Rate
Figure Global Cunninghamella Market Size Growth Rate
Figure Global Apophysomyces Market Size Growth Rate
Figure Global Saksenaea Market Size Growth Rate
Figure Global Lichtheimia (Absidia) Market Size Growth Rate
Figure Global Mucor Market Size Growth Rate
Figure Mucormycosis Consumed in Hospitals & Clinics
Figure Global Mucormycosis Market: Hospitals & Clinics (2013-2018) ($ Millions)
Figure Global Hospitals & Clinics YoY Growth ($ Millions)
Figure Mucormycosis Consumed in Medical Institutes
Figure Global Mucormycosis Market: Medical Institutes (2013-2018) ($ Millions)
Figure Global Medical Institutes YoY Growth ($ Millions)
Figure Mucormycosis Consumed in Research Organization
Figure Global Mucormycosis Market: Research Organization (2013-2018) ($ Millions)
Figure Global Research Organization YoY Growth ($ Millions)
Table Global Mucormycosis Market Size by Application (2013-2018) ($ Millions)
Table Global Mucormycosis Market Size Market Share by Application (2013-2018)
Figure Global Mucormycosis Market Size Market Share by Application (2013-2018)
Figure Global Mucormycosis Market Size in Hospitals & Clinics Growth Rate
Figure Global Mucormycosis Market Size in Medical Institutes Growth Rate
Figure Global Mucormycosis Market Size in Research Organization Growth Rate
Table Global Mucormycosis Revenue by Players (2016-2018) ($ Millions)
Table Global Mucormycosis Revenue Market Share by Players (2016-2018)
Figure Global Mucormycosis Revenue Market Share by Players in 2017
Table Global Mucormycosis Key Players Head office and Products Offered
Table Mucormycosis Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Mucormycosis Market Size by Regions 2013-2018 ($ Millions)
Table Global Mucormycosis Market Size Market Share by Regions 2013-2018
Figure Global Mucormycosis Market Size Market Share by Regions 2013-2018
Figure Americas Mucormycosis Market Size 2013-2018 ($ Millions)
Figure APAC Mucormycosis Market Size 2013-2018 ($ Millions)
Figure Europe Mucormycosis Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Mucormycosis Market Size 2013-2018 ($ Millions)
Table Americas Mucormycosis Market Size by Countries (2013-2018) ($ Millions)
Table Americas Mucormycosis Market Size Market Share by Countries (2013-2018)
Figure Americas Mucormycosis Market Size Market Share by Countries in 2017
Table Americas Mucormycosis Market Size by Type (2013-2018) ($ Millions)
Table Americas Mucormycosis Market Size Market Share by Type (2013-2018)
Figure Americas Mucormycosis Market Size Market Share by Type in 2017
Table Americas Mucormycosis Market Size by Application (2013-2018) ($ Millions)
Table Americas Mucormycosis Market Size Market Share by Application (2013-2018)
Figure Americas Mucormycosis Market Size Market Share by Application in 2017
Figure United States Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Canada Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Table APAC Mucormycosis Market Size by Countries (2013-2018) ($ Millions)
Table APAC Mucormycosis Market Size Market Share by Countries (2013-2018)
Figure APAC Mucormycosis Market Size Market Share by Countries in 2017
Table APAC Mucormycosis Market Size by Type (2013-2018) ($ Millions)
Table APAC Mucormycosis Market Size Market Share by Type (2013-2018)
Figure APAC Mucormycosis Market Size Market Share by Type in 2017
Table APAC Mucormycosis Market Size by Application (2013-2018) ($ Millions)
Table APAC Mucormycosis Market Size Market Share by Application (2013-2018)
Figure APAC Mucormycosis Market Size Market Share by Application in 2017
Figure China Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Japan Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Korea Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure India Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Australia Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Table Europe Mucormycosis Market Size by Countries (2013-2018) ($ Millions)
Table Europe Mucormycosis Market Size Market Share by Countries (2013-2018)
Figure Europe Mucormycosis Market Size Market Share by Countries in 2017
Table Europe Mucormycosis Market Size by Type (2013-2018) ($ Millions)
Table Europe Mucormycosis Market Size Market Share by Type (2013-2018)
Figure Europe Mucormycosis Market Size Market Share by Type in 2017
Table Europe Mucormycosis Market Size by Application (2013-2018) ($ Millions)
Table Europe Mucormycosis Market Size Market Share by Application (2013-2018)
Figure Europe Mucormycosis Market Size Market Share by Application in 2017
Figure Germany Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure France Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure UK Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Italy Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Russia Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Spain Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Mucormycosis Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Mucormycosis Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Mucormycosis Market Size Market Share by Countries in 2017
Table Middle East & Africa Mucormycosis Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Mucormycosis Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Mucormycosis Market Size Market Share by Type in 2017
Table Middle East & Africa Mucormycosis Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Mucormycosis Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Mucormycosis Market Size Market Share by Application in 2017
Figure Egypt Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Israel Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Mucormycosis Market Size Growth 2013-2018 ($ Millions)
Figure Global Mucormycosis arket Size Forecast (2018-2023) ($ Millions)
Table Global Mucormycosis Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Mucormycosis Market Size Market Share Forecast by Regions
Figure Americas Mucormycosis Market Size 2018-2023 ($ Millions)
Figure APAC Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Europe Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Mucormycosis Market Size 2018-2023 ($ Millions)
Figure United States Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Canada Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Mexico Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Brazil Mucormycosis Market Size 2018-2023 ($ Millions)
Figure China Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Japan Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Korea Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Mucormycosis Market Size 2018-2023 ($ Millions)
Figure India Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Australia Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Germany Mucormycosis Market Size 2018-2023 ($ Millions)
Figure France Mucormycosis Market Size 2018-2023 ($ Millions)
Figure UK Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Italy Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Russia Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Spain Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Egypt Mucormycosis Market Size 2018-2023 ($ Millions)
Figure South Africa Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Israel Mucormycosis Market Size 2018-2023 ($ Millions)
Figure Turkey Mucormycosis Market Size 2018-2023 ($ Millions)
Figure GCC Countries Mucormycosis Market Size 2018-2023 ($ Millions)
Table Global Mucormycosis Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Mucormycosis Market Size Market Share Forecast by Type (2018-2023)
Table Global Mucormycosis Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Mucormycosis Market Size Market Share Forecast by Application (2018-2023)
Table Abbott Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table Abbott Laboratories Mucormycosis Revenue and Gross Margin (2016-2018)
Figure Abbott Laboratories Mucormycosis Market Share (2016-2018)
Table Biocon Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biocon Mucormycosis Revenue and Gross Margin (2016-2018)
Figure Biocon Mucormycosis Market Share (2016-2018)
Table Cadila Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cadila Pharmaceuticals Mucormycosis Revenue and Gross Margin (2016-2018)
Figure Cadila Pharmaceuticals Mucormycosis Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Mucormycosis Revenue and Gross Margin (2016-2018)
Figure Novartis Mucormycosis Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Mucormycosis Revenue and Gross Margin (2016-2018)
Figure Merck Mucormycosis Market Share (2016-2018)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Mucormycosis Revenue and Gross Margin (2016-2018)
Figure Roche Mucormycosis Market Share (2016-2018)
Table Bristol Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol Myers Squibb Mucormycosis Revenue and Gross Margin (2016-2018)
Figure Bristol Myers Squibb Mucormycosis Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Mucormycosis Revenue and Gross Margin (2016-2018)
Figure Pfizer Mucormycosis Market Share (2016-2018)


More Publications